Animal models of obesity and metabolic syndrome: potential tools for Alzheimer's disease research.
Emerging evidence suggests that components of the metabolic syndrome either in isolation or in aggregate may impact the onset or severity of neurodegenerative processes, including those physiologic changes that lead to Alzheimer's Disease (AD). Several animal models that were originally designed to interrogate the metabolic syndrome are readily available. These models can now be used to support studies that may provide new mechanistic links between the metabolic syndrome and neurodegeneration. In addition, animal strains currently being generated and phenotyped through the efforts of an array of NIDDK-supported projects are likely to provide novel and better tools to advance Alzheimer's disease research in the near future.
Abraham
Kristin M
KM
Division of Diabetes, Endocrinology and Metabolic Diseases, National Institute of Diabetes, Digestive and Kidney Diseases, NIH, Bethesda, MD 20892-5460, USA. abrahamk@mail.nih.gov
D000544:Alzheimer Disease / Q000209:etiology*; D000818:Animals; D004195:Disease Models, Animal; D006801:Humans; D008659:Metabolic Diseases / Q000150:complications*; D009765:Obesity / Q000150:complications*; D012106:Research